Product Description
The RNase inhibitor (RNase inhibitor) is a specific ribonuclease (RNase) inhibitor that exists in human placenta. The principle of specific inactivation of RNase is: non-covalent bond with RNase to form a complex, resulting in RNase is inactivated. The product is a purified recombinant murine RNase inhibitor expressed in E.coli in soluble form. It can extensively inhibit various RNases (RNase A, B, C). According to RT-PCR and RT-qPCR, this product can be compatible with Hifai r TM V Reverse Transcriptase (Cat#11300) and various DNA Polymerases. Compared to human-derived RNase inhibitors, the murine version lacks two oxidation-sensitive cysteines, giving it higher antioxidant stability and making it better suited for DTT-sensitive applications like qPCR. The product can be applied to 1st strand synthesis of cDNA, polysome isolation, in vitro reverse transcription and in vitro cell-free translation system.
This glycerol-free formulation is specially designed for lyophilization.
Features
Components
Shipping and Storage
This product should be stored at 2-8°C for 6 months.
Applications
Figures
1.Highly effective RNase inhibition activity
Figure 1. RNase Inhibitor Effectively Inhibits RNase Activity 2.Compatible with various lyophilized forms for flexible use
Figure 2. Freeze-Dried Product Forms Using Yeasen's RNA lyophilizable reagent (Cat#16645ES), which contains Murine RNase Inhibitor (200 U/µL, Glycerol-free) (Cat#10703), both in situ freeze-drying and freeze-dried microspheres were successfully prepared. The in situ freeze-dried product showed a smooth surface with no collapse or tube gap. The microspheres were uniform, plump, and smooth. 3.No residual exonuclease, nicking enzyme, or RNase.
Figure 3. No detectable residues of exonuclease, nicking enzyme, or RNase. N * stands for negative control; 1, 2 and 3 are 3 batches.
Safety Data Sheet
Manuals
Related Blog